Supernus Pharmaceuticals
SUPN
SUPN
208 hedge funds and large institutions have $895M invested in Supernus Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 87 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 87
26% less capital invested
Capital invested by funds: $1.22B → $895M (-$322M)
49% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 47
Holders
208
Holding in Top 10
1
Calls
$2.35M
Puts
$2.36M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$7.77M | |
| 3 | +$6.24M | |
| 4 |
Two Sigma Advisers
New York
|
+$4.5M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$4M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$17.4M | |
| 3 | -$6.04M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$4.65M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.63M |